Rare Observations of Sustained Symptomatic Improvement with Botulinum Toxin Type A Injections in Facial and Cervical Dystonia: Case Series
Objective: To describe prolonged improvement in patients with involuntary facial and cervical movements after BTX-A therapy. Background: Botulinum toxin type A (BTX-A) treatment is considered…Muscarinic receptor antagonism beyond M4 is required for efficacy in a preclinical model of dystonia and Parkinson’s disease
Objective: To inform the target activity profile of future movement disorder therapies, pre-clinical studies quantified the contribution of M4 receptor occupancy (M4RO) to reversal of…Adherence with Digital Outcome Measures in Focal Dystonias
Objective: We assessed patient adherence with an app-based patient-centered outcome (PCO) tool for focal dystonia in a prospective study to determine the impact of dystonia…Challenges in Airway Management after Deep Brain Stimulation in DYT1 Dystonia: a Case Report
Objective: To highlight the challenges in upper airway management following deep brain stimulation (DBS) in patients with severe, medically refractory DYT1 dystonia and to emphasize…National Survey of DYT/PARK-GCH1 (Segawa Disease) in Japan
Objective: To clarify clinical features of Segawa Disease (SD) in Japan. Background: Prof Segawa discovered SD 50 years ago, and GCH-1 gene mutations were linked…Long-Term Therapeutic Effect of Botulinum Neurotoxin Type A (BoNT-A) in Cervical Dystonia: A Case Series.
Objective: To evaluate the long-term therapeutic effect of Botulinum neurotoxin type A (BoNT-A) in cervical dystonia. Background: Cervical dystonia is the most common adult-onset focal…The Vodka Trial: Clinical and Genetic Characteristics of Alcohol Responsiveness in Laryngeal Dystonia
Objective: To determine the objective characteristics of alcohol responsiveness in laryngeal dystonia (LD) using a standardized alcohol challenge test and genetic testing. Background: LD is…GPi-DBS responsive laryngeal dystonia in SGCE myoclonus-dystonia
Objective: To describe a case of DBS-responsive laryngeal dystonia in the setting of myoclonus-dystonia secondary to e-sarcoglycan (SGCE) mutation. Background: DBS is emerging as a…Understanding Family and Clinician Perspectives on Treatment Decision-Making for Acute Dystonia Exacerbations in Children
Objective: Primary: To identify factors influencing the decision to provide acute pharmacological treatment for dystonia exacerbations in hospitalized pediatric patients. Secondary: To assess the alignment…Development and Testing of a Smartphone Application to Capture Patient-Centered Outcome (PCO) Measures for Dystonia
Objective: Develop a smartphone application to collect patient-centered outcome (PCO) measures for dystonia. Background: PCO measures tailored for each major adult-onset focal dystonia subtype (Cervical…
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 43
- Next Page »